Sanofi partners with Cornell University's Weill Cornell Medical College to develop new anti-infective agents to treat drug-susceptible and drug-resistant strains of TB

Sanofi

France / Large-Cap Biopharma (>=$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Cornell University

U.S. / Academic

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced